(S)-N-((3-(3-Fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide
95%
- Product Code: 60171
CAS:
154590-66-6
| Molecular Weight: | 336.36 g./mol | Molecular Formula: | C₁₆H₂₁FN₄O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD18089805 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, protected from light, stored under inert gas |
Product Description:
This compound is primarily utilized in the development of antibacterial agents, particularly targeting resistant bacterial strains. Its structure is designed to inhibit bacterial protein synthesis, making it effective against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). It is often incorporated into pharmaceutical formulations for treating skin infections, pneumonia, and other bacterial infections. Additionally, its unique mechanism of action reduces the likelihood of cross-resistance with other antibiotics, enhancing its therapeutic potential in clinical settings. Research is ongoing to explore its efficacy in broader antimicrobial applications and combination therapies.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿4,446.00 |
+
-
|
| 0.250 | 10-20 days | ฿6,687.00 |
+
-
|
| 1.000 | 10-20 days | ฿23,337.00 |
+
-
|
(S)-N-((3-(3-Fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide
This compound is primarily utilized in the development of antibacterial agents, particularly targeting resistant bacterial strains. Its structure is designed to inhibit bacterial protein synthesis, making it effective against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). It is often incorporated into pharmaceutical formulations for treating skin infections, pneumonia, and other bacterial infections. Additionally, its unique mechanism of action reduces the likelihood of cross-resistance with other antibiotics, enhancing its therapeutic potential in clinical settings. Research is ongoing to explore its efficacy in broader antimicrobial applications and combination therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :